Articles Published in 2011 Articles | CenterWatch News Online

Articles Published in 2011

Prev 10 21 22 23 24 25 26 27 28 29 30 Next 10

Cedars-Sinai Medical Center selects Voalté's iPhone platform

Tuesday, November 8, 2011 03:25 PM

Voalté, a clinical communication technology and software for healthcare institutions, and Cedars-Sinai Medical Center have launched Voalté’s point-of-care communication solution, consolidating voice, alarm and text on the versatile iPhone platform.

More... »

Battelle, Molecular Imaging collaborate in R&D

Tuesday, November 8, 2011 03:07 PM

Battelle, an independent research and development organization, has enhanced its discovery and development services through a collaboration with Molecular Imaging, a provider of small-scale nonclinical in vivo multi-modality imaging services.

More... »

BioTrak Research launches Patient Recruiters International

Tuesday, November 8, 2011 11:34 AM

BioTrak Research, a contract research organization, has launched Patient Recruiters International, a full-service patient recruitment organization.

More... »

Sentinel Captial acquires WellSpring Pharmaceutical

Tuesday, November 8, 2011 10:31 AM

Sentinel Capital Partners has acquired WellSpring Pharmaceutical. Sentinel completed the transaction alongside Ancor Capital Partners.

More... »

Dendreon names Fenton to board of directors

Tuesday, November 8, 2011 10:12 AM

Dendreon has named Dennis M. Fenton to the board of directors, effective November 8, 2011.

More... »

Axio Research expands services into China

Monday, November 7, 2011 02:07 PM

Axio Research, a North American independent data coordinating center, has expanded its services into Shanghai, China.

More... »

NPS Pharmaceuticals' phase III REPLACE study shows positive results

Monday, November 7, 2011 01:06 PM

NPS Pharmaceuticals has reported positive top-line results from REPLACE, a phase III registration study of NPSP558, the company's bioengineered replica of human parathyroid hormone (rhPTH 1-84), in adult hypoparathyroidism patients. NPS has received orphan drug status for NPSP558 for the treatment of hypoparathyroidism, a rare endocrine disorder in which the body produces insufficient levels of parathyroid hormone, the principal regulator of calcium and phosphorus, and for which there is no FDA-approved replacement therapy. The symptoms of hypoparathyroidism are typically managed with large doses of oral calcium supplementation and active vitamin D therapy to reduce the severity of symptoms. The prolonged use of oral calcium supplementation and active vitamin D therapy may result in serious long-term health complications.

More... »

CoreRx launches FLEXITAB

Monday, November 7, 2011 12:27 PM

CoreRx has further enhanced its offering by adding the Bosch Manesty FLEXITAB, a fully automated, single station tablet press with a multi-layer tablet function, giving it the unique capacity to produce multi-layer (up to three-layer) tablets using a minimal amount of material. Its variable punch displacement and dwell time can be set to simulate compression on any rotary press using compression forces up to100kN.

More... »

Report: Clinical trials approved in Russia on course in third quarter

Monday, November 7, 2011 11:26 AM

The number of new studies approved in Russia during the third quarter of 2011 reached last year’s level, with the Ministry of Health and Social Development of the Russian Federation (MoH) approving 132 new clinical trials of all types, including local and bioequivalence studies, according to Synergy Research Group (SynRG), a Russia-based CRO. That’s only two trials below the number approved in the year-ago quarter.

More... »